FCMT
LLY icon

Founders Capital Management (Texas)’s Eli Lilly LLY Stock Holding History

Founders Capital Management (Texas)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25
Closed -$19.4K – 378
2024
Q1 		$19.4K Hold
25
– – 0.01% 236
2023
Q4 		$14.6K Hold
25
– – 0.01% 259
2023
Q3 		$13.4K Buy
+25
New +$12.9K 0.01% 264

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Founders Capital Management (Texas)'s LLY Position: Q2 2024 in Review

Founders Capital Management (Texas) sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 25 shares — an estimated $19.4K sold.

Founders Capital Management (Texas) first reported a position in LLY in Q3 2023 and held it in 3 quarters. The position peaked at $19.4K in Q1 2024. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Founders Capital Management (Texas) reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 25 Eli Lilly shares in Q2 2024, an estimated $19.4K.
  • Founders Capital Management (Texas) first reported a position in Eli Lilly in Q3 2023 and held it in 3 quarters.
  • Founders Capital Management (Texas)'s Eli Lilly position peaked at $19.4K in Q1 2024.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2024, filed 10 Jul 2024.